Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anna E. Gluskin currently holds 226,127 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna E. Gluskin has been a net buyer of GNBT stock. They have purchased $390.9K and sold $0 worth of shares.
Anna E. Gluskin's most recent insider trade was on Nov 16, 2019, when they purchased 10,000 shares at $0.51 per share.
Anna E. Gluskin serves as Executive at GENEREX BIOTECHNOLOGY CORP (GNBT). They have executed 5 insider transactions totaling $390.9K over their tenure at the company.
Anna E. Gluskin holds the position of Executive at GENEREX BIOTECHNOLOGY CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Anna E. Gluskin has shown a buying trading pattern, with $390.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Anna E. Gluskin was on Mar 21, 2014, when they purchased $216.0K worth of ESAQ shares. This transaction involved 864,000 shares at $0.25 per share.
Anna E. Gluskin currently owns 226,127 shares of GENEREX BIOTECHNOLOGY CORP (GNBT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anna E. Gluskin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anna E. Gluskin has 5 Form 4 filings on record as an insider at GENEREX BIOTECHNOLOGY CORP.
Set alerts for Anna E. Gluskin and 40,000+ other insiders.